TAM
NVRO

Trillium Asset Management’s NEVRO CORP. NVRO Stock Holding History

Trillium Asset Management’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-11,066
Closed -$951K – 275
2019
Q3 		$951K Sell
11,066
-14
-0.1% -$1.06K 0.04% 187
2019
Q2 		$718K Buy
11,080
+1,288
+13% +$80.2K 0.03% 184
2019
Q1 		$612K Buy
9,792
+735
+8% +$34.6K 0.03% 198
2018
Q4 		$352K Buy
9,057
+45
+0.5% +$2K 0.02% 210
2018
Q3 		$514K Buy
9,012
+134
+2% +$8.38K 0.03% 200
2018
Q2 		$709K Buy
8,878
+162
+2% +$13.4K 0.04% 190
2018
Q1 		$755K Buy
8,716
+70
+0.8% +$5.65K 0.04% 188
2017
Q4 		$597K Buy
8,646
+97
+1% +$7.76K 0.03% 188
2017
Q3 		$777K Buy
8,549
+138
+2% +$11.8K 0.04% 180
2017
Q2 		$626K Buy
+8,411
New +$674K 0.04% 186

Other funds holding NVRO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $653B AUM 32.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return